Home About Us Management Products Ambien Ativan Klonopin Meridia Provigil Phentermine Soma Valium Xanax Investor Relations News Contact Us Media Retailers

First Name
Last Name
Submit to receive updates on our latest products


XenaCare Holdings, Inc. (OTCBB: XCHO) engages in the formulation, marketing, and distribution of healthcare products. XenaCare is constantly seeking new and innovative products such as it's latest introduction of Cobroxin, the first and only Stage 2 OTC pain medication. Additional clinical products include XenaCor, which supports the lowering of serum cholesterol, C-reactive protein, and homocysteine levels to support cardiovascular health; XenaTri for lowering triglycerides and raising HDL to support cardiovascular health; and XenaZyme Plus that increases the body's oxygen carrying capacities designed to support digestion. XenaCare's clinical products also include BRS, the Body Replenishment System that targets drug nutrient depletion.





In addition, the company offers formulations for the lifestyle performance market, which consists of sports line for athletes, including SunPill that is formulated to protect the skin when exposed to damaging ultraviolet rays. XenaCare markets its products through the Internet, Pharmacies, Physician's offices, Mass food and Drug stores. XenaCare Holdings was founded in 2005 and is based in Delray Beach, Florida.

On May 26th, 2009 XenaCare was awarded the USA marketing rights to Cobroxin. Cobroxin is the first over-the-counter pain reliever clinically proven to treat chronic pain. The drug which was developed by Nutra Pharma's wholly owned drug discovery subsidiary, ReceptoPharm is available as an oral spray for lower back pain, migraines, neck aches, shoulder pain, cramps and neuralgia, and as a topical gel for repetitive stress, arthritis and joint pain. Cobroxin is all-natural, non-addictive, non-narcotic, non-opiate, long lasting and said to be clinically proven to be more effective than morphine.

XenaCare, a company specializing in branding, marketing and retail distribution of consumer healthcare products, has announced that it has received the exclusive license to market and distribute a cellular cleanse and detoxification product called Zeolite from Mineral Sciences designed as an effective solution for removing heavy metals and toxins from the body. Research has also shown that the product's ingredients may help reduce viral replication and support healthy blood sugar levels. Additionally, this product improves nutrient absorption, supports immune system function and reduces symptoms of allergies.

Copyright © 2000-2009, XenaCare Holdings. All Rights Reserved. Designed by Infinet Solutions